Genetic Predictors of Benign Course of Ulcerative Colitis - A North American Inflammatory Bowel Disease Genetics Consortium Study

Inflammatory Bowel Diseases

Volumn 22, Issue 10, 2016, Pages 2311-2316

  Kopylov, Uri ^a   Boucher, Gabrielle ^b,c   Waterman, Matti ^d   Rivers, Claudia R ^e   Patel, Mohini ^f   Cho, Judy H ^g   Colombel, Jean F ^g   Duerr, Richard H ^e   Binion, David ^e   McGovern, Dermot P B ^h   Schumm, Phillip P ⁱ   Brant, Steven R ^j   Silverberg, Mark S ^d   Rioux, John D ^b,c   Bitton, Alain ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f YALE UNIVERSITY   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

benign course; genetic determinators; ulcerative colitis

Indexed keywords

ADULT; ARTICLE; BIOLOGICAL THERAPY; CHROMOSOME 15; CHROMOSOME 19; CHROMOSOME 5; CHROMOSOME 6; COLON RESECTION; DISEASE COURSE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; GENETIC ASSOCIATION STUDY; GENETICS; MIDDLE AGED; NORTH AMERICA; YOUNG ADULT;

ADULT; CHROMOSOMES, HUMAN, PAIR 5; COLITIS, ULCERATIVE; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; NORTH AMERICA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84988649118     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000913     Document Type: Article

References (18)

1. Cottone M, Scimeca D, Mocciaro F, et al. Clinical course of ulcerative colitis. Dig Liver Dis. 2008;40(suppl 2):S247-S252
2. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11
3. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440
4. Haritunians T, Taylor KD, Targan SR, et al. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis. 2010;16: 1830-1840
5. Waterman M, Knight J, Dinani A, et al. Predictors of outcome in ulcerative colitis. Inflamm Bowel Dis. 2015;21:2097-2105
6. Nemetz A, Nosti-Escanilla MP, Molnar T, et al. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics. 1999;49:527-531
7. Potocnik U, Ferkolj I, Glavac D, et al. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun. 2004;5:530-539
8. Nam SY, Kim N, Kim JS, et al. Heat shock protein gene 70-2 polymorphism is differentially associated with the clinical phenotypes of ulcerative colitis and Crohn's disease. J Gastroenterol Hepatol. 2007;22:1032-1038
9. Heresbach D, Alizadeh M, Reumaux D, et al. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? J Autoimmunity. 1996;9: 777-784
10. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124
11. Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387:156-167
12. Dassopoulos T, Nguyen GC, Bitton A, et al. Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney diseases (NIDDK) IBD genetics Consortium (IBDGC). Inflamm Bowel Dis. 2007;13:975-983
13. Stallmach A, Nickel L, Lehmann T, et al. Parameters of a severe disease course in ulcerative colitis. World J Gastroenterol. 2014;20:12574-12580
14. Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1 01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015;47:172-179
15. Goyette P, Boucher G, Mallon D. High-density mapping of the MHC identifies a shared role for HLA-DRB1 01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015;47: 172-179
16. Concha EG, Fernandez-Arquero M, Lopez-Nava G, et al. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology. 2000;119:1491-1495
17. Bouma G, Crusius JB, Garcia-Gonzalez MA, et al. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol. 1999;115:294-300
18. Fowler EV, Doecke J, Simms LA, et al. ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity. Am J Gastroenterol. 2008;103:2519-2526